A Phase 1/2 trial of Moderna’s mRNA-1083 found strong immune responses against both viruses, similar to existing vaccines. Most side effects were mild.

5 hours ago 3
A Phase 1/2 trial of Moderna’s mRNA-1083 found strong immune responses against both viruses, similar to existing vaccines. Most side effects were mild. submitted by /u/calliope_kekule
[link] [comments]
Read Entire Article